TABLE 2.

Segmented linear regression analysis results of the monthly number of patients who initiated treatment with medicines of interest before and after the public health insurance coverage.

Outcome variable	Coefficient		95% CI	p-value
Number of lung cancer patients who initiated treatment with medicines of interest	Intercept	−0.758	—	—
	Baseline trend	0.245	−1.168 to 1.657	0.726
	Level change	25.657	14.049–37.266	<0.001
	Trend change	0.438	0.159–1.936	<0.001
	Afterward trend	0.683	0.185–1.181	<0.001